Table 2.
Isolate ID | Resistance status | blaTEM | blaSHV | blaCTX-M | Phylogenetic group |
---|---|---|---|---|---|
UPEC 1 | MDR | + | − | + | B2 |
UPEC 2 | MDR | + | − | + | A |
UPEC 3 | MDR | + | − | + | B2 |
UPEC 4 | MDR | + | − | − | B2 |
UPEC 5 | MDR | + | − | + | B2 |
UPEC 6 | MDR | + | − | + | D |
UPEC 7 | MDR | + | − | + | A |
UPEC 8 | MDR | + | + | + | D |
UPEC 9 | MDR | + | − | + | B2 |
UPEC 10 | MDR | + | − | + | B2 |
UPEC 11 | MDR | + | − | + | B2 |
UPEC 12 | MDR | + | − | + | B2 |
UPEC 13 | MDR | + | − | + | B2 |
UPEC 14 | MDR | + | + | + | A |
UPEC 15 | MDR | − | − | + | Ungrouped |
UPEC 16 | MDR | + | − | + | A |
UPEC 17 | MDR | + | + | + | F |
UPEC 18 | MDR | + | + | + | A |
UPEC 19 | MDR | + | + | + | B1 |
UPEC 20 | MDR | + | − | + | B2 |
UPEC 21 | MDR | + | − | + | D |
UPEC 22 | MDR | + | − | + | B2 |
UPEC 23 | MDR | + | − | + | B2 |
MRSN/SHV/489100 | − | + | − | ND | |
CTX control | − | − | + | ND | |
TEM control | + | − | − | ND | |
Nuclease-free water | − | − | − | ND |
Phylogenetic groups are based on the new Clermont quadruplex method (Derakhshandeh et al.30).
CTX-M, cefotaximase-Munich; MDR, multidrug-resistant; ND, not done; SHV, sulfhydryl variable; TEM, temoneira.